Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Nutrition & Metabolism
|
January 28, 2017
Dietary supplementation with bovine-derived milk fat globule membrane lipids promotes neuromuscular development in growing rats
James F Markworth, Brenan Durainayagam, Vandre C Figueiredo, et al.
Molecular Nutrition & Food Research
|
January 30, 2018
Dairy Protein Supplementation Modulates the Human Skeletal Muscle microRNA Response to Lower Limb Immobilization
Randall F D'Souza, Nina Zeng, Vandre C Figueiredo, et al.
The Journal of Nutrition
|
June 2, 2019
The Degree of Aminoacidemia after Dairy Protein Ingestion Does Not Modulate the Postexercise Anabolic Response in Young Men: A Randomized Controlled Trial
Alex H Chan, Randall F D'Souza, Joseph W Beals, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
November 11, 2017
Impact of dairy protein during limb immobilization and recovery on muscle size and protein synthesis; a randomized controlled trial
Cameron J Mitchell, Randall F D'Souza, Sarah M Mitchell, et al.
Gastroenterology
|
October 27, 2009
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients
Henk W Reesink, Gregory C Fanning, Khalid Abou Farha, et al.
The Journal of Gene Medicine
|
January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients
Janet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2012
TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage
Benoit Devogelaere, Jan Martin Berke, Leen Vijgen, et al.
Human Gene Therapy
|
March 17, 2004
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients
Rafael G Amado, Ronald T Mitsuyasu, Joseph D Rosenblatt, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435
Oliver Lenz, Thierry Verbinnen, Tse-I Lin, et al.
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase
Jan Martin Berke, Leen Vijgen, Sophie Lachau-Durand, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Nutrition & Metabolism
|
January 28, 2017
Dietary supplementation with bovine-derived milk fat globule membrane lipids promotes neuromuscular development in growing rats
James F Markworth, Brenan Durainayagam, Vandre C Figueiredo, et al.
Molecular Nutrition & Food Research
|
January 30, 2018
Dairy Protein Supplementation Modulates the Human Skeletal Muscle microRNA Response to Lower Limb Immobilization
Randall F D'Souza, Nina Zeng, Vandre C Figueiredo, et al.
The Journal of Nutrition
|
June 2, 2019
The Degree of Aminoacidemia after Dairy Protein Ingestion Does Not Modulate the Postexercise Anabolic Response in Young Men: A Randomized Controlled Trial
Alex H Chan, Randall F D'Souza, Joseph W Beals, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
November 11, 2017
Impact of dairy protein during limb immobilization and recovery on muscle size and protein synthesis; a randomized controlled trial
Cameron J Mitchell, Randall F D'Souza, Sarah M Mitchell, et al.
Gastroenterology
|
October 27, 2009
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients
Henk W Reesink, Gregory C Fanning, Khalid Abou Farha, et al.
The Journal of Gene Medicine
|
January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients
Janet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2012
TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage
Benoit Devogelaere, Jan Martin Berke, Leen Vijgen, et al.
Human Gene Therapy
|
March 17, 2004
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients
Rafael G Amado, Ronald T Mitsuyasu, Joseph D Rosenblatt, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435
Oliver Lenz, Thierry Verbinnen, Tse-I Lin, et al.
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase
Jan Martin Berke, Leen Vijgen, Sophie Lachau-Durand, et al.
Page
of 8